BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schill G, Iesalnieks I, Haimerl M, Müller-Wille R, Dendl LM, Wiggermann P, Schleder S, Rennert J, Ott C, Agha A, Stroszczynski C, Schreyer AG. Assessment of disease behavior in patients with Crohn's disease by MR enterography. Inflamm Bowel Dis 2013;19:983-90. [PMID: 23474779 DOI: 10.1097/MIB.0b013e31828029dd] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Yoon K, Chang KT, Lee HJ. MRI for Crohn’s Disease: Present and Future. Biomed Res Int. 2015;2015:786802. [PMID: 26413543 DOI: 10.1155/2015/786802] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
2 Eder P, Michalak M, Katulska K, Lykowska-Szuber L, Krela-Kazmierczak I, Stawczyk-Eder K, Klimczak K, Szymczak A, Linke K. Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn's disease treated with anti-tumor necrosis factor antibodies. Sci Rep 2015;5:10223. [PMID: 25993615 DOI: 10.1038/srep10223] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
3 Eder P, Katulska K, Krela-Kaźmierczak I, Stawczyk-Eder K, Klimczak K, Szymczak A, Linke K, Łykowska-Szuber L. The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn's disease activity. Abdom Imaging 2015;40:2210-8. [PMID: 26048698 DOI: 10.1007/s00261-015-0466-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
4 Puylaert CA, Tielbeek JA, Bipat S, Stoker J. Grading of Crohn's disease activity using CT, MRI, US and scintigraphy: a meta-analysis. Eur Radiol. 2015;25:3295-3313. [PMID: 26080794 DOI: 10.1007/s00330-015-3737-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]